Nader Francois is a director of Tourmaline Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Talaris Therapeutics, Inc.
14 Jun 23
4
Moderna, Inc.
5 May 23
4/A
Talaris Therapeutics, Inc.
13 Sep 22
4
Talaris Therapeutics, Inc.
25 Jul 22
4
Talaris Therapeutics, Inc.
13 Jun 22
4
Moderna, Inc.
12 May 22
4
Moderna, Inc.
2 May 22
4
Talaris Therapeutics, Inc.
16 Dec 21
4
ACCELERON PHARMA INC
22 Nov 21
4
ALEXION PHARMACEUTICALS, INC.
23 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 23 | TRML Tourmaline Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 2.54 | 41,000 | 104.14 k | 41,000 |
3 May 23 | MRNA Moderna | Stock Option Common Stock | Grant | Acquire A | No | No | 130.14 | 6,134 | 798.28 k | 6,134 |